Publicação
Physiological role of erythrocyte nitric oxide
| dc.contributor.author | Saldanha, Carlota | |
| dc.date.accessioned | 2018-07-17T11:38:53Z | |
| dc.date.available | 2018-07-17T11:38:53Z | |
| dc.date.issued | 2016 | |
| dc.description | © 2016 – IOS Press and the authors. All rights reserved | pt_PT |
| dc.description.abstract | Nitric oxide (NO) produced by endothelial cells interacts with erythrocyte through band 3 protein, being scavenged by haemoglobin. A signal transduction mechanism involving protein Gi and protein band 3 stimulates erythrocyte NO efflux when acetylcholine (ACh) binds to erythrocyte membrane acetylcholinesterase. Binding of normal plasma fibrinogen (Fib) levels, to erythrocyte membrane CD47 decreases theNOefflux. When high Fib concentration andACh were present the efflux of NO from erythrocytes was normalized. The increased NO efflux from erythrocytes in presence of high Fib concentration and band 3 phosphorylation is reinforced in the presence of 4N1K an agonist peptide of CD47. When both Fib and 4N1K are present the NO efflux from erythrocytes is higher or not affected according lower or high levels of cAMP. Erythrocyte NO efflux in patients with systemic lupus erythematous and rheumatoid attrite was significantly negative associated with carotid intima-media thickness. In patients with amyotrophic lateral sclerosis erythrocyte NO content is preserved and an inverse association between respiratory function and NO efflux from the erythrocyte was verified. Sepsis patients before dead at 24 h showed higher efflux ofNOfrom erythrocytes thatworsening the blood sub lingual microcirculation observed by high unequal blood flow and high microvascular flow index. The in vivo animal models either of inflammation or of hypertension evidenced that the NO efflux from erythrocyte decrease as a compensatory mechanism. All studies conducted since 2000 where we demonstrated the existence NO inside the erythrocyte by fluorescence microscopy, and after their signaling pathway needs more development translational research for news therapeutics and further application in not invasive therapy to vascular inflammatory diseases. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Clinical Hemorheology and Microcirculation 64 (2016) 517–520 | pt_PT |
| dc.identifier.doi | 10.3233/CH-168028 | pt_PT |
| dc.identifier.issn | 1386-0291 | |
| dc.identifier.uri | http://hdl.handle.net/10451/34189 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | IOS Press | pt_PT |
| dc.relation.publisherversion | https://www.iospress.nl/journal/clinical-hemorheology-and-microcirculation/ | pt_PT |
| dc.subject | Nitric oxide | pt_PT |
| dc.subject | Erythrocyte | pt_PT |
| dc.subject | Fibrinogen | pt_PT |
| dc.subject | Signal transduction | pt_PT |
| dc.subject | Inflammation | pt_PT |
| dc.subject | Vascular diseases | pt_PT |
| dc.title | Physiological role of erythrocyte nitric oxide | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 520 | pt_PT |
| oaire.citation.issue | 4 | pt_PT |
| oaire.citation.startPage | 517 | pt_PT |
| oaire.citation.title | Clinical Hemorheology and Microcirculation | pt_PT |
| oaire.citation.volume | 64 | pt_PT |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |